New Approaches To Neuroblastoma Therapy Consortium
Clinical trials sponsored by New Approaches To Neuroblastoma Therapy Consortium, explained in plain language.
-
New hope for kids with tough cancer: drug combo trial launches
Disease control OngoingThis early-phase study tests a three-drug combination (sorafenib, cyclophosphamide, and topotecan) in children and young adults with neuroblastoma that has come back or not responded to treatment. The main goal is to find the safest dose of sorafenib when given with the other two…
Phase: PHASE1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated May 17, 2026 07:05 UTC
-
Immune cells take on childhood cancer in new trial
Disease control OngoingThis early-stage trial tests a new combination treatment for children with neuroblastoma that has come back or not responded to standard therapy. It uses the child's own natural killer (NK) cells, grown in a lab, along with an antibody drug (dinutuximab) and sometimes a drug call…
Phase: PHASE1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Scientists hunt for genetic clues in tough childhood cancer
Knowledge-focused OngoingThis study looks at tumor samples from 93 children and young adults with neuroblastoma that has come back or not responded to treatment. The goal is to find specific genetic changes or immune system markers that could guide future therapies. No new treatment is given; instead, re…
Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC